Francisco J. Esteva
Northwell Health(US)Lenox Hill Hospital(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Monoclonal and Polyclonal Antibodies Research, Advanced Breast Cancer Therapies
Most-Cited Works
- → PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients(2004)1,856 cited
- → National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers(2008)1,130 cited
- → Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3(2018)1,086 cited
- → Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer(2006)917 cited
- → Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer(2019)821 cited
- → Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells(2005)795 cited